Posts
February 12 2024
Client Alert: New York Credit Card Surcharge Law Updated
On December 13, 2023, Governor Kathy Hochul signed a bill updating and clarifying New York’s credit card surcharge rules. This law is now in effect and businesses must comply with the updated credit card surcharge requirements.
Click here to read the alert.
February 12 2024 Event
Webinar | Navigating Legitimate Fees: Legal Billing Practices for Restaurants
Amanda Fugazy, a member of the Firm, was invited by the New York State Restaurant Association to present in their webinar – Navigating Legitimate Fees: Legal Billing Practices for Restaurants. Ms. Fugazy will be guiding attendees through the legal landscape surrounding fees, including service charges, gratuity, credit card fees and other applicable charges. Stay informed and ensure your restaurant operates within the bounds of the law while providing exceptional service to your customers.
Click here for more information.
February 12 2024
ToughBuilt Industries, Inc. announced the closing of its Public Offering in the amount of $3,500,000. EG&S acted as counsel to the Placement Agent.
February 11 2024
Energous Corporation announced the closing of its Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.
February 10 2024
Revelation Biosciences, Inc. announced the closing of its Public Offering in the amount of $6,200,000. EG&S acted as counsel to the Placement Agent.
February 09 2024
Gryphon Digital Mining, Inc. and Akerna Corp. announced the closing of its previously announced merger. Following completion of the merger, the combined company is expected to begin trading at market open on February 9, 2024, on The Nasdaq Capital Market on a reverse stock split basis, under the new name “Gryphon Digital Mining, Inc.” and under the symbol “GRYP”. The transaction is valued at approximately $120,000,000. EGS acted as counsel to Gryphon Digital Mining, Inc.
February 09 2024
Lexaria Bioscience Corp. announced the closing of its Registered Direct offering in the amount of $3,600,000. EG&S acted as counsel to the Placement Agent.
February 09 2024
Clearside Biomedical, Inc. announced the closing of its Registered Direct offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.